Chris Morten
@cmorten.bsky.social
Associate professor of law at @nyulaw.bsky.social. Director of the Science, Health & Information Clinic (SHIC). He/him. https://chrismorten.com/
And now posted to SSRN!
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
October 30, 2025 at 3:14 PM
And now posted to SSRN!
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
We urge further exploration & investment in truly public pharma—a "public option" in pharma. Empower NIH & other public agencies to take products all the way from bench to market without necessarily yielding IP rights and control of the research agenda to an industry partner.
14/
14/
October 21, 2025 at 7:52 PM
We urge further exploration & investment in truly public pharma—a "public option" in pharma. Empower NIH & other public agencies to take products all the way from bench to market without necessarily yielding IP rights and control of the research agenda to an industry partner.
14/
14/
We close the paper with some thoughts on how NIH and other public agencies might do better.
How to escape platform thinking and orient R&D investments around the best science rather than the biggest returns?
13/
How to escape platform thinking and orient R&D investments around the best science rather than the biggest returns?
13/
October 21, 2025 at 7:52 PM
We close the paper with some thoughts on how NIH and other public agencies might do better.
How to escape platform thinking and orient R&D investments around the best science rather than the biggest returns?
13/
How to escape platform thinking and orient R&D investments around the best science rather than the biggest returns?
13/
A multidisciplinary effort, with the brilliant and inspiring @sariahmed.bsky.social, Janice Graham & @mattherder.bsky.social.
Published open access! (After we paid Elsevier's outrageous $3800 OA fee....)
2/
Published open access! (After we paid Elsevier's outrageous $3800 OA fee....)
2/
October 21, 2025 at 7:52 PM
A multidisciplinary effort, with the brilliant and inspiring @sariahmed.bsky.social, Janice Graham & @mattherder.bsky.social.
Published open access! (After we paid Elsevier's outrageous $3800 OA fee....)
2/
Published open access! (After we paid Elsevier's outrageous $3800 OA fee....)
2/
October 13, 2025 at 6:34 PM
Full list of confirmed speakers!
Join us!
Join us!
September 19, 2025 at 3:54 PM
Full list of confirmed speakers!
Join us!
Join us!
Excited to announce an upcoming event w @nyuengelberg.org!
My first back at @nyulaw.bsky.social!
"Fixing a Broken System: The Path to Public Pharma in New York"
5:30-7 pm Thur Sep. 25, 2025 @ NYU
Co-hosted w T1International & @racepowerpolicy.org!
Zoom & IRL, free & open to all! Join us!
My first back at @nyulaw.bsky.social!
"Fixing a Broken System: The Path to Public Pharma in New York"
5:30-7 pm Thur Sep. 25, 2025 @ NYU
Co-hosted w T1International & @racepowerpolicy.org!
Zoom & IRL, free & open to all! Join us!
August 19, 2025 at 9:17 PM
Excited to announce an upcoming event w @nyuengelberg.org!
My first back at @nyulaw.bsky.social!
"Fixing a Broken System: The Path to Public Pharma in New York"
5:30-7 pm Thur Sep. 25, 2025 @ NYU
Co-hosted w T1International & @racepowerpolicy.org!
Zoom & IRL, free & open to all! Join us!
My first back at @nyulaw.bsky.social!
"Fixing a Broken System: The Path to Public Pharma in New York"
5:30-7 pm Thur Sep. 25, 2025 @ NYU
Co-hosted w T1International & @racepowerpolicy.org!
Zoom & IRL, free & open to all! Join us!
Hello from New York City, where “good billionaire” “Democrat” Michael Bloomberg is hard at work with DoorDash and Bill Ackman to make corrupt sex offender Republican collaborator Andrew Cuomo our mayor.
June 18, 2025 at 1:12 PM
Hello from New York City, where “good billionaire” “Democrat” Michael Bloomberg is hard at work with DoorDash and Bill Ackman to make corrupt sex offender Republican collaborator Andrew Cuomo our mayor.
🚨 New from the Science, Health & Information Clinic at Columbia Law School:
A "know your rights"-style guide for New York State doctors and other clinicians on the legal protections provided by NY's telehealth abortion "shield law."
We've published the guide with @drsforamerica.bsky.social.
🧵
1/
A "know your rights"-style guide for New York State doctors and other clinicians on the legal protections provided by NY's telehealth abortion "shield law."
We've published the guide with @drsforamerica.bsky.social.
🧵
1/
March 17, 2025 at 12:58 PM
🚨 New from the Science, Health & Information Clinic at Columbia Law School:
A "know your rights"-style guide for New York State doctors and other clinicians on the legal protections provided by NY's telehealth abortion "shield law."
We've published the guide with @drsforamerica.bsky.social.
🧵
1/
A "know your rights"-style guide for New York State doctors and other clinicians on the legal protections provided by NY's telehealth abortion "shield law."
We've published the guide with @drsforamerica.bsky.social.
🧵
1/
PhRMA's deregulatory agenda for the 2nd Trump administration, in one slide.
Magic AI pixie dust, "new and different forms of evidence," and "modernization" of "regulatory expectations" all code words for fewer, smaller, and weaker clinical trials to prove safety and efficacy.
Magic AI pixie dust, "new and different forms of evidence," and "modernization" of "regulatory expectations" all code words for fewer, smaller, and weaker clinical trials to prove safety and efficacy.
February 21, 2025 at 8:12 PM
PhRMA's deregulatory agenda for the 2nd Trump administration, in one slide.
Magic AI pixie dust, "new and different forms of evidence," and "modernization" of "regulatory expectations" all code words for fewer, smaller, and weaker clinical trials to prove safety and efficacy.
Magic AI pixie dust, "new and different forms of evidence," and "modernization" of "regulatory expectations" all code words for fewer, smaller, and weaker clinical trials to prove safety and efficacy.
I'll have more to say about this landmark case and landmark settlement in the days ahead.
8/8
8/8
January 22, 2025 at 3:47 PM
I'll have more to say about this landmark case and landmark settlement in the days ahead.
8/8
8/8
And a group of 11 professors of law, medicine & public health, working w me, my outstanding students Kiran Zelbo & Ben Anderson, and my clinic (the Science, Health & Information Clinic) filed a second amicus brief, explaining the policy harms of allowing Gilead to exploit HHS.
6/
6/
January 22, 2025 at 3:46 PM
And a group of 11 professors of law, medicine & public health, working w me, my outstanding students Kiran Zelbo & Ben Anderson, and my clinic (the Science, Health & Information Clinic) filed a second amicus brief, explaining the policy harms of allowing Gilead to exploit HHS.
6/
6/
HHS faced an uphill battle, appealing an unfavorable jury verdict, but the merits & momentum were on its side.
A coalition of HIV/AIDS advocacy orgs, led by @prep4allnow.bsky.social, filed an amicus brief in support of HHS, underscoring the novelty & nonobviousness of CDC's invention of PrEP.
4/
A coalition of HIV/AIDS advocacy orgs, led by @prep4allnow.bsky.social, filed an amicus brief in support of HHS, underscoring the novelty & nonobviousness of CDC's invention of PrEP.
4/
January 22, 2025 at 3:45 PM
HHS faced an uphill battle, appealing an unfavorable jury verdict, but the merits & momentum were on its side.
A coalition of HIV/AIDS advocacy orgs, led by @prep4allnow.bsky.social, filed an amicus brief in support of HHS, underscoring the novelty & nonobviousness of CDC's invention of PrEP.
4/
A coalition of HIV/AIDS advocacy orgs, led by @prep4allnow.bsky.social, filed an amicus brief in support of HHS, underscoring the novelty & nonobviousness of CDC's invention of PrEP.
4/
As my quotes reveal, I'm disappointed in HHS's settlement. It lets Gilead off the hook for years of patent infringement, bad faith exploitation of CDC & NIH, and profiteering off patients.
HHS effectively traded a >$1 billion claim for a release from much smaller breach-of-contract claims.
3/
HHS effectively traded a >$1 billion claim for a release from much smaller breach-of-contract claims.
3/
January 22, 2025 at 3:45 PM
As my quotes reveal, I'm disappointed in HHS's settlement. It lets Gilead off the hook for years of patent infringement, bad faith exploitation of CDC & NIH, and profiteering off patients.
HHS effectively traded a >$1 billion claim for a release from much smaller breach-of-contract claims.
3/
HHS effectively traded a >$1 billion claim for a release from much smaller breach-of-contract claims.
3/
Chris Yasiejko (@bloomberglaw.com) has a new follow-up story on the landmark settlement in US v. Gilead—the billion-dollar patent fight over HIV PrEP.
I'm quoted, along with Jeremiah Johnson (@prep4allnow.bsky.social), Mark Harrington (@treatmentactiongroup.org) and @reshmagar.bsky.social.
1/
I'm quoted, along with Jeremiah Johnson (@prep4allnow.bsky.social), Mark Harrington (@treatmentactiongroup.org) and @reshmagar.bsky.social.
1/
January 22, 2025 at 3:43 PM
Chris Yasiejko (@bloomberglaw.com) has a new follow-up story on the landmark settlement in US v. Gilead—the billion-dollar patent fight over HIV PrEP.
I'm quoted, along with Jeremiah Johnson (@prep4allnow.bsky.social), Mark Harrington (@treatmentactiongroup.org) and @reshmagar.bsky.social.
1/
I'm quoted, along with Jeremiah Johnson (@prep4allnow.bsky.social), Mark Harrington (@treatmentactiongroup.org) and @reshmagar.bsky.social.
1/
News just broke that HHS & DOJ have settled the landmark United States v. Gilead HIV PrEP patent litigation.
Terms are undisclosed but seem favorable to Gilead.
I'm quoted in the statement below from @prep4allnow.bsky.social.
PrEP4All didn't mince words. I'll have more to say in the days ahead.
Terms are undisclosed but seem favorable to Gilead.
I'm quoted in the statement below from @prep4allnow.bsky.social.
PrEP4All didn't mince words. I'll have more to say in the days ahead.
January 17, 2025 at 1:29 PM
News just broke that HHS & DOJ have settled the landmark United States v. Gilead HIV PrEP patent litigation.
Terms are undisclosed but seem favorable to Gilead.
I'm quoted in the statement below from @prep4allnow.bsky.social.
PrEP4All didn't mince words. I'll have more to say in the days ahead.
Terms are undisclosed but seem favorable to Gilead.
I'm quoted in the statement below from @prep4allnow.bsky.social.
PrEP4All didn't mince words. I'll have more to say in the days ahead.
Among other things, our brief emphasizes the havoc that state-by-state restrictions on FDA-approved drugs could cause for prescribing guidelines, telemedicine, medical education, and American health care writ large.
Direct link to the brief: storage.courtlistener.com/recap/gov.us...
Direct link to the brief: storage.courtlistener.com/recap/gov.us...
November 4, 2024 at 8:27 PM
Among other things, our brief emphasizes the havoc that state-by-state restrictions on FDA-approved drugs could cause for prescribing guidelines, telemedicine, medical education, and American health care writ large.
Direct link to the brief: storage.courtlistener.com/recap/gov.us...
Direct link to the brief: storage.courtlistener.com/recap/gov.us...
It's official!
I'm delighted to visit NYU Law this fall, and to bring the Science, Health & Information Clinic here for the semester.
I'm honored to work with 8 terrific NYU students!
Stay tuned for further announcements! We and our clients have lots planned! :)
I'm delighted to visit NYU Law this fall, and to bring the Science, Health & Information Clinic here for the semester.
I'm honored to work with 8 terrific NYU students!
Stay tuned for further announcements! We and our clients have lots planned! :)
August 28, 2024 at 7:47 PM
It's official!
I'm delighted to visit NYU Law this fall, and to bring the Science, Health & Information Clinic here for the semester.
I'm honored to work with 8 terrific NYU students!
Stay tuned for further announcements! We and our clients have lots planned! :)
I'm delighted to visit NYU Law this fall, and to bring the Science, Health & Information Clinic here for the semester.
I'm honored to work with 8 terrific NYU students!
Stay tuned for further announcements! We and our clients have lots planned! :)
New 9th Cir amicus brief!
With KEI, UAEM & Dr. Reshma Ramachandran, repped by Harvard's Cyberlaw Clinic.
The appeal may set new FOIA precedent—specifically, what "confidential commercial information" can be withheld.
Fighting corporate secrecy!
Check it out!:
clinic.cyber.harvard.edu/2024/07/24/c...
With KEI, UAEM & Dr. Reshma Ramachandran, repped by Harvard's Cyberlaw Clinic.
The appeal may set new FOIA precedent—specifically, what "confidential commercial information" can be withheld.
Fighting corporate secrecy!
Check it out!:
clinic.cyber.harvard.edu/2024/07/24/c...
July 24, 2024 at 8:17 PM
New 9th Cir amicus brief!
With KEI, UAEM & Dr. Reshma Ramachandran, repped by Harvard's Cyberlaw Clinic.
The appeal may set new FOIA precedent—specifically, what "confidential commercial information" can be withheld.
Fighting corporate secrecy!
Check it out!:
clinic.cyber.harvard.edu/2024/07/24/c...
With KEI, UAEM & Dr. Reshma Ramachandran, repped by Harvard's Cyberlaw Clinic.
The appeal may set new FOIA precedent—specifically, what "confidential commercial information" can be withheld.
Fighting corporate secrecy!
Check it out!:
clinic.cyber.harvard.edu/2024/07/24/c...
Chapter in brief: New health care devices, including at-home diagnostics, generate & aggregate data on patients’ health at a staggering pace. Yet much of that data is inaccessible because it is held in data siloes, most often cloud services controlled by manufacturers. ... 98/
June 8, 2024 at 6:24 PM
Chapter in brief: New health care devices, including at-home diagnostics, generate & aggregate data on patients’ health at a staggering pace. Yet much of that data is inaccessible because it is held in data siloes, most often cloud services controlled by manufacturers. ... 98/
We extract 3 primary lessons: 1. The benefits of research on otherwise secret data are cascading & unpredictable; 2. Law without institutions to implement the law is insufficient; 3. Data access regimes must be tailored to the different sorts of data they make available. 84/
June 6, 2024 at 4:57 PM
We extract 3 primary lessons: 1. The benefits of research on otherwise secret data are cascading & unpredictable; 2. Law without institutions to implement the law is insufficient; 3. Data access regimes must be tailored to the different sorts of data they make available. 84/
Thus, the paper! "Researcher Access to Social Media Data: Lessons from Clinical Trial Data Sharing" extracts lessons from the mature, (mostly) successful world of researcher access to clinical trial data and applies those lessons to social media. 83/
June 6, 2024 at 4:57 PM
Thus, the paper! "Researcher Access to Social Media Data: Lessons from Clinical Trial Data Sharing" extracts lessons from the mature, (mostly) successful world of researcher access to clinical trial data and applies those lessons to social media. 83/
And, in 2020, Facebook cited both privacy and trade secrecy concerns in comments submitted to the FTC, opposing data portability rules that would have facilitated more research. about.fb.com/wp-content/u... 74/
June 6, 2024 at 4:53 PM
And, in 2020, Facebook cited both privacy and trade secrecy concerns in comments submitted to the FTC, opposing data portability rules that would have facilitated more research. about.fb.com/wp-content/u... 74/